THERAPEUTIC AREA
savePain
Acute and chronic pain management.
also known as: analgesia, chronic pain, pain management
🐶 often sniffed alongside
top 8- tagRecall49 co-mentions · 43 sources
- tagOrthopedics47 co-mentions · 13 sources
- tagOncology16 co-mentions · 7 sources
- tagWomen's Health15 co-mentions · 4 sources
- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN15 co-mentions · 7 sources
- drugbupivacaine14 co-mentions · 14 sources
- drugImmunology14 co-mentions · 3 sources
- tagImmunology14 co-mentions · 3 sources
drugs
89
catalysts
15
news
561
companies
78
Top drugs
view all →Marketed
acetaminophen ER
Dysmenorrhea
1021 catalysts
MarketedMETHADONE HYDROCHLORIDE
Pain
343 catalysts
MarketedBUPRENORPHINE HYDROCHLORIDE
Pain
270 catalysts
Marketedcarbamazepine ER
Complex Partial Seizure
222 catalysts
MarketedMEPERIDINE HYDROCHLORIDE
Pain
165 catalysts
MarketedKapanol
Pain
148 catalysts
Marketedtramadol hydrochloride ER
Pain
146 catalysts
MarketedOXYCODONE HYDROCHLORIDE
$AVTR · 133 catalysts
🐶 Top companies
view all →Recent catalysts
view all →Apr 30, 2026
phase 2 completion
Police General Hospital — acetaminophen (Phase II Trial Completion)
acetaminophen ER
→
Apr 30, 2026
phase 2 completion
Beijing Jishuitan Hospital — undisclosed anesthetic drug (Phase II Trial Completion)
undisclosed anesthetic drug
→
Apr 30, 2026
phase 2 completion
Assaf Harofeh Medical Center — acetaminophen (Phase II Trial Completion)
acetaminophen ER
→
Apr 30, 2026
phase 1 completion
$ECL273.70+0.90%
Ecolab Inc — (acetaminophen + ibuprofen) (Phase I Trial Completion)
(acetaminophen + ibuprofen)
→
Apr 30, 2026
phase 0 trial completion
Ruijin Hospital — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 0 trial completion
Kunming Yan'an Hospital — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 29, 2026
phase iii iv trial initiation
Chettinad Hospital and Research Institute — undisclosed local anesthesia (Phase III/IV Trial Initiation)
undisclosed local anesthesia
→
Apr 28, 2026
phase iv trial initiation
Rajendra Institute of Medical Sciences — levobupivacaine (Phase IV Trial Initiation)
levobupivacaine
→
Apr 27, 2026
phase 2 initiation
Central South University Xiangya Hospital 3 — HRS-2129 (Phase II Trial Initiation)
HRS-2129
→
Apr 27, 2026
phase 2 initiation
Yichun Maternal and Child health Care Hospital — sufentanil (Phase II Trial Initiation)
sufentanil
→
Recent news
view all →- EAK Distribution LLC Recalls HOME GROWN Green Sprouting Calabrese Broccoli Seeds, 8 oz, Heirloom Because of Possible Health Riskfda recalls · 2d ago
- Foghorn cuts 40% of workforcebiospace · 2d ago
- How big is Pennsylvania’s measles outbreak?stat · 3d ago
- Top journal’s special issue on women’s health casts spotlight on menopause and painstat · 3d ago
- STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may awaitstat · 4d ago
- Gias Foods, Inc. Recalls Bettergoods Authentic Italian Lemon Alfredo Fettuccine Because of Possible Health Riskfda recalls · 4d ago
- U.S. poised to boot legal immigrants from Medicaid, including refugees and sex-trafficking victimsstat · 4d ago
- Rural MAHA followers say Trump hasn’t improved health of their communities, poll findsstat · 4d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that